Literature DB >> 26116594

Clot Strength as Measured by Thrombelastography Correlates with Platelet Reactivity in Stroke Patients.

Richard S P Huang1, Mark M McDonald2, Jeremy S Wetzel2, Jorge Kawano-Castillo2, Stephanie Parker2, Joancy Archeval-Lao2, Chunyan Cai2, Mohammad H Rahbar2, Andy N D Nguyen1, Samer J Baba1, James C Grotta3.   

Abstract

OBJECTIVE: Platelet reactivity may be important in the management of patients with stroke. However, degree of platelet reactivity has not been correlated with Thrombelastography (TEG(®)) parameters in stroke. We sought to detect a correlation between TEG(®) values and clot platelet reactivity in ex vivo clots of stroke patients.
METHODS: We collected venous blood from 40 patients with stroke. TEG(®) measurements were carried out and residual clots were fixed in 10% formalin immediately following completion of TEG(®). The formalin specimens were embedded in paraffin blocks, cut at 4 micrometers, and stained with CD 61 (immunohistochemical stain used to detect platelets) with appropriate controls. Under light microscopy, three pathologists blinded to TEG(®) results independently graded CD61 intensity (how aggregated/intense the CD61 stained) into a low and high group, as a proposed measurement representing the platelet reactivity of the clot. We compared pre-tPA-TEG(®) values among groups with different CD 61 intensities.
RESULTS: After adjusting for confounding factors, we found statistically significant correlation between CD61 staining and several TEG(®) parameters (Delta and CD61 staining intensity (p=0.047); Angle and CD61 staining intensity grade (p=0.04); and G and CD61 staining intensity grade (p=0.04)).
CONCLUSIONS: Clot strength on TEG(®) as measured by Delta, Angle, and G correlates with a clot with greater platelet reactivity.
© 2015 by the Association of Clinical Scientists, Inc.

Entities:  

Mesh:

Year:  2015        PMID: 26116594

Source DB:  PubMed          Journal:  Ann Clin Lab Sci        ISSN: 0091-7370            Impact factor:   1.256


  4 in total

1.  Thrombelastography does not predict clinical response to rtPA for acute ischemic stroke.

Authors:  Mark M McDonald; Jeremy Wetzel; Stuart Fraser; Andrea Elliott; Ritvij Bowry; Jorge F Kawano-Castillo; Chunyan Cai; Navdeep Sangha; Jessica Messier; Amanda Hassler; Joancy Archeval-Lao; Stephanie A Parker; Mohammad H Rahbar; Evan G Pivalizza; Tiffany R Chang; James C Grotta
Journal:  J Thromb Thrombolysis       Date:  2016-04       Impact factor: 2.300

2.  Effects of Blood Components and Whole Blood in a Model of Severe Trauma-Induced Coagulopathy.

Authors:  Gregory R Stettler; Ernest E Moore; Geoffrey R Nunns; Marguerite Kelher; Anirban Banerjee; Christopher C Silliman
Journal:  J Surg Res       Date:  2020-12-02       Impact factor: 2.192

3.  Apolipoprotein A-I, elevated in trauma patients, inhibits platelet activation and decreases clot strength.

Authors:  Wilbert L Jones; Christopher R Ramos; Anirban Banerjee; Ernest E Moore; Kirk C Hansen; Julia R Coleman; Marguerite Kelher; Keith B Neeves; Christopher C Silliman; Jorge Di Paola; Brian Branchford
Journal:  Platelets       Date:  2022-06-05       Impact factor: 4.236

4.  Hypercoagulability as Measured by Thrombelastography May Be Associated with the Size of Acute Ischemic Infarct-A Pilot Study.

Authors:  Adam Wiśniewski; Aleksandra Karczmarska-Wódzka; Joanna Sikora; Przemysław Sobczak; Adam Lemanowicz; Karolina Filipska; Robert Ślusarz
Journal:  Diagnostics (Basel)       Date:  2021-04-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.